Radiation Therapy Use Low in End-Stage Cancer
Although the overall use of radiation treatment among elderly end-stage cancer patients is low during their final month of life, many receive >10 days of treatment.
Although the overall use of radiation treatment among elderly end-stage cancer patients is low during their final month of life, many receive >10 days of treatment.
The American Society of Clinical Oncology (ASCO) has presented recommendations for promoting high-quality cancer survivorship care.
From 2000-2009, there was a general decrease in the death rates for all cancers combined for men and women, although the incidence of some cancers continued to rise.
A considerable proportion of male cancer survivors do not attend follow-up appointments to monitor their fertility or to discuss disposal of banked sperm.
For patients with advanced cancer, nurse-led monitoring and optimized treatment of physical symptoms significantly improves cancer-related fatigue.
Icon Bioscience announced that melphalan intraocular injection, the company’s investigational product for the treatment of retinoblastoma, has been granted Orphan Drug Designation by the FDA.
For adults with average or lower than average education or health knowledge, use of the Internet can reduce cancer fatalism.
Although oncology nurses and physicians feel that spiritual care (SC) is an important, appropriate, and beneficial component of end-of-life (EOL) care for patients with advanced cancer, it is infrequently offered, primarily due to a lack of training.
Productivity losses due to disability days for employees being treated for cancer represent about 20% of the overall health care expenditure.
Compared to patients with advanced cancer who were simply told about the likelihood of success with cardiopulmonary resuscitation (CPR), those who viewed a video of CPR were less likely to opt for its use.